In colorectal cancer, Huang et al. [8] and Miyo et al. [14] found that SIRT4 levels were reduced in patients with colorectal cancer and were associated with poor prognosis; moreover, SIRT4 inhibited the proliferation of colon cancer cells. This evidence concerns the gene SIRT4 and malignant colon neoplasm.